Study: Home monoclonal antibody program averted COVID hospital care

Oct 14, 2021

During a 14-day follow-up, only 8 of 144 infused patients (5.6%) were hospitalized, despite all being at high risk.

Mary Van Beusekom | News Writer | CIDRAP NewsOct 14, 2021During a 14-day follow-up, only 8 of 144 infused patients (5.6%) were hospitalized, despite all being at high risk.Read More

Leave a Reply

Your email address will not be published.